Streetbeat News

Stock Prices

ABL

AGO

AMBC

CRD

ITIC

KFS

MHLA

MHLD

MRAI

RELI

SLQT

WDH

In Friday's intraday session, insurance stocks saw notable movements. Gainers included Ambac Financial Group (AMBC), Investors Title (ITIC), Assured Guaranty (AGO), SelectQuote (SLQT), Abacus Life (ABL), and Kingsway Financial Servs (KFS), with increases ranging from 3.03% to 10.6%. Losers were Waterdrop (WDH), Marpai (MRAI), Maiden Hldgs (MHLD), Reliance Global Group (RELI), Maiden Holdings, Ltd. 6.625% Notes due 2046 (MHLA), and Crawford (CRD), with declines between 2.55% and 4.84%. The movements were based on trading volumes and market cap changes, with specific mention of Waterdrop's Q3 earnings release.

Portfolio Pulse from Benzinga Insights

December 08, 2023 | 5:40 pm

COIN

Coinbase Global's stock (COIN) is trading higher, correlating with an increase in Bitcoin's value.

Portfolio Pulse from Benzinga Newsdesk

December 08, 2023 | 5:39 pm

CVX

HES

The FTC has requested additional information from Chevron Corp (CVX) and Hess Corp (HES) regarding their merger, extending the HSR waiting period. Chevron also announced a 2024 capex budget of $15.5 to $16.5 billion, with significant investments in U.S. shale, the Permian Basin, and Gulf of Mexico projects. The company aims to maintain capital discipline and grow free cash flow to increase shareholder returns. CVX shares rose by 1.07% to $143.94.

Portfolio Pulse from Lekha Gupta

December 08, 2023 | 5:39 pm

BLUE

Trading in shares of Bluebird Bio (BLUE) has been halted pending news. The halt is due to an announcement or event that is significant enough to potentially affect the stock price once trading resumes. Investors are awaiting further details to understand the implications of the pending news.

Portfolio Pulse from Benzinga Newsdesk

December 08, 2023 | 5:37 pm

CDMO

RBC Capital analyst Sean Dodge has maintained an Outperform rating on Avid Bioservices (NASDAQ:CDMO) but has reduced the price target from $15 to $7.

Portfolio Pulse from Benzinga Newsdesk

December 08, 2023 | 5:36 pm

BLUE

Bluebird Bio, Inc. (NASDAQ:BLUE) announced FDA approval of LYFGENIA for sickle cell disease treatment in patients 12+ with a history of vaso-occlusive events. LYFGENIA, a one-time gene therapy, aims to resolve these events and treat the disease's underlying cause. The approval is based on data from the HGB-206 study, with 94% of evaluable patients experiencing resolved severe VOEs. Bluebird plans to make LYFGENIA available in early 2024 through its Qualified Treatment Centers. The company will host a conference call to discuss the approval.

Portfolio Pulse from Benzinga Newsdesk

December 08, 2023 | 5:36 pm

CHWY

Chewy Inc (CHWY) reported Q3 2023 results with revenue of $2.74 billion, missing estimates by $0.02 billion, but EPS of 15 cents beat the six-cent loss expected. Analysts from Needham, RBC Capital, Piper Sandler, and Morgan Stanley have expressed concerns over top-line challenges and adjusted their price targets accordingly. The company's stock price declined by 2% in aftermarket trading. Management is prepared for a potential demand moderation in FY24 and has already cut 8% of corporate employees. Analysts are looking forward to the company's investor day for insights on long-term strategies.

Portfolio Pulse from Anusuya Lahiri

December 08, 2023 | 5:35 pm

GMS

RBC Capital analyst Mike Dahl has maintained a 'Sector Perform' rating on GMS Inc. (NYSE:GMS) and increased the price target from $68 to $70.

Portfolio Pulse from Benzinga Newsdesk

December 08, 2023 | 5:34 pm

Planet Labs shares dropped after reporting mixed Q3 results. Craig-Hallum downgraded the stock from Buy to Hold with a $3 price target.

Portfolio Pulse from Benzinga Newsdesk

December 08, 2023 | 5:32 pm

AENT

CONN

CURV

DLA

FFIE

GDHG

HCDIP

KAVL

QSG

SPGC

XPOF

In Friday's intraday session, several consumer discretionary stocks experienced significant movements. Faraday Future (FFIE) saw a 29.6% increase, while Torrid Holdings (CURV) rose by 20.6% following their Q3 earnings release. Sacks Parente Golf (SPGC), Harbor Custom Dev (HCDIP), QuantaSing Group (QSG), and Conn's (CONN) also saw gains. Conversely, Golden Heaven Group Hldgs (GDHG), Kaival Brands Innovations (KAVL), Delta Apparel (DLA), Alliance Entertainment (AENT), RH (RH), and Xponential Fitness (XPOF) faced declines, with RH and DLA dropping post Q3 and Q4 earnings reports, respectively.

Portfolio Pulse from Benzinga Insights

December 08, 2023 | 5:31 pm